All articles tagged with #cholangiocarcinoma
Keaton Herzer, diagnosed with cholangiocarcinoma, was told he’d remain in lifelong treatment, but a newer targeted therapy shrank his tumors enough to qualify for a liver transplant. Post‑transplant, doctors see no signs of cancer, offering new hope and reshaping his outlook and that of others facing similar diagnoses.
FDA approved Bizengri (zenocutuzumab-zbco) for adults with unresectable or metastatic NRG1 fusion–positive cholangiocarcinoma, the seventh approval under the Commissioner’s National Priority Voucher program. Efficacy comes from a 19-patient single-arm trial showing a 36.8% overall response; safety concerns include infusion-related reactions, interstitial lung disease/pneumonitis, and cardiac effects, with Breakthrough Therapy and Orphan Drug designations previously granted. A June 4, 2026 public meeting will discuss CNPV program details, with written comments due by June 29, 2026.
John Djahanshah Refoua, an Oscar-nominated film editor who worked on Avatar and Avatar: The Way of Water, has died at the age of 62 due to cholangiocarcinoma. Despite his illness, he continued to work on James Cameron's Avatar 3 until his final weeks. Refoua's career as a film editor included titles like Transformers: The Last Knight, The Magnificent Seven, and Southpaw. He also worked on TV shows like Law & Order and CSI: Miami.